Evidence map›Paper›PMID 33117347›Full record

ArticleFrontiers in immunology2020

Excretory/Secretory Products From

Zixia Wang, Chunyue Hao, Qinghui Zhuang, Bin Zhan, Ximeng Sun, Jingjing Huang, Yuli Cheng, Xinping Zhu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. A NovelInternational journal of molecular sciences · 2024
    Article
  16. Article
  17. Effect ofACS pharmacology & translational science · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Zixia WangDepartment of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Chunyue HaoDepartment of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Qinghui ZhuangDepartment of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Bin ZhanDepartment of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.
Ximeng SunDepartment of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Jingjing HuangDepartment of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Yuli ChengDepartment of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Xinping ZhuDepartment of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Capital Medical University · CNBaylor College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helminth-modulated macrophages contribute to attenuating inflammation in inflammatory bowel diseases. The programmed death 1 (PD-1) plays an important role in macrophage polarization and is essential in the maintenance of immune system homeostasis. Here, we investigate the role of PD-1-mediated polarization of M2 macrophages and the protective effects of excretory/secretory products from

Indexed as

Bodily SecretionsAnimalsCell PolarityColitisDextran SulfateDisease Models, AnimalFemaleGene Knockout TechniquesMacrophage ActivationMacrophages, PeritonealMaleMiceMice, Inbred C57BLMice, Inbred ICRMice, KnockoutProgrammed Cell Death 1 ReceptorDextran SulfatePdcd1 protein, mouseProgrammed Cell Death 1 Receptorexcretory/secretory productsinflammatory bowel diseasemacrophagesprogrammed death 1Trichinella spiralis

Identifiers

PMID33117347
PMCPMC7575908
OpenAlexW3090744476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.